Lecanamab Ushers in a New Era of Anti-Amyloid Therapy for Alzheimer's Disease
Ann Neurol
.
2023 May;93(5):877-880.
doi: 10.1002/ana.26643.
Epub 2023 Mar 29.
Authors
Erik S Musiek
1
,
Eric McDade
1
,
David M Holtzman
1
Affiliation
1
Department of Neurology, Hope Center for Neurological Disorders, and Knight Alzheimer Disease Research Center, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
PMID:
36919987
DOI:
10.1002/ana.26643
No abstract available
Publication types
Review
Research Support, Non-U.S. Gov't
MeSH terms
Alzheimer Disease* / therapy
Amyloid
Amyloid beta-Peptides
Humans
Substances
Amyloid beta-Peptides
Amyloid